These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6694063)

  • 1. Synthesis and anticonvulsant properties of some 2-aminoethanesulfonic acid (taurine) derivatives.
    Andersen L; Sundman LO; Lindén IB; Kontro P; Oja SS
    J Pharm Sci; 1984 Jan; 73(1):106-8. PubMed ID: 6694063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anticonvulsant taurine derivatives.
    Kontro P; Lindén IB; Gothóni G; Oja SS
    Prog Clin Biol Res; 1983; 125():211-20. PubMed ID: 6878405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant activity of some 2-aminoethanesulphonic acid (taurine) derivatives.
    Oja SS; Kontro P; Lindén IB; Gothóni G
    Eur J Pharmacol; 1983 Feb; 87(2-3):191-8. PubMed ID: 6840189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant activity of 2-phthalimidoethanesulphonamides: New derivatives of taurine.
    Lindén IB; Gothóni G; Kontro P; Oja SS
    Neurochem Int; 1983; 5(3):319-24. PubMed ID: 20487955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-independent taurine binding to brain synaptic membranes.
    Kontro P; Oja SS
    Cell Mol Neurobiol; 1983 Jun; 3(2):183-7. PubMed ID: 6317180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis and anticonvulsant activity of some omega-phthalimido-N-phenylacetamide and propionamide derivatives.
    Soyer Z; Kilic FS; Erol K; Pabuccuoglu V
    Arch Pharm (Weinheim); 2004 Feb; 337(2):105-11. PubMed ID: 14981667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the antiepileptic actions of phenobarbital and phenytoin by the taurine transport inhibitor, guanidinoethane sulfonate.
    Izumi K; Kishita C; Nakagawa K; Huxtable RJ; Shimizu T; Koja T; Fukuda T
    Eur J Pharmacol; 1985 Apr; 110(2):219-24. PubMed ID: 3987813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anticonvulsant activity of ethyl 2,2-dimethyl-1-(2-substitutedhydrazinecarboxamido) cyclopropanecarboxylate derivatives.
    Zhong M; Zhang Y; He X
    Chem Biol Drug Des; 2014 Aug; 84(2):234-41. PubMed ID: 24571574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticonvulsant effects of some aminoalkanolic derivatives of xanthone.
    Marona H
    Pharmazie; 1998 Oct; 53(10):672-6. PubMed ID: 9812332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzothiazole incorporated barbituric acid derivatives: synthesis and anticonvulsant screening.
    Siddiqui N; Ahsan W
    Arch Pharm (Weinheim); 2009 Aug; 342(8):462-8. PubMed ID: 19565603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of sodium-independent taurine binding to brain synaptic membranes.
    Kontro P; Oja SS
    Prog Clin Biol Res; 1985; 179():249-59. PubMed ID: 4059217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticonvulsant activity of 1-(2-(8-(benzyloxy)quinolin-2-yl)-1-butyrylcyclopropyl)-3-substituted urea derivatives.
    He X; Zhong M; Yang J; Wu Z; Xiao Y; Guo H; Hu X
    Chem Biol Drug Des; 2012 May; 79(5):771-9. PubMed ID: 22304806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticonvulsant activity evaluation of 6-substituted-[1,2,4]triazolo[3,4-a](tetrazolo[5,1-a])phthalazine derivatives.
    Bian M; Deng XQ; Gong GH; Wei CX; Quan ZS
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):792-800. PubMed ID: 22994853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Mannich-bases as Potential Anticonvulsants: Syntheses, Characterization and Biological Evaluation.
    Keshari AK; Tewari A; Verma SS; Saraf SK
    Cent Nerv Syst Agents Med Chem; 2017; 17(3):219-228. PubMed ID: 28714383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced taurine contents and modification of anticonvulsive effects of phenobarbital and phenytoin by guanidinoethane sulfonate in mice.
    Izumi K; Kishita C; Nakagawa K; Huxtable RJ; Shimizu T; Koja T; Fukuda T
    Prog Clin Biol Res; 1985; 179():425-34. PubMed ID: 4059222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.
    Kumari S; Mishra CB; Tiwari M
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1092-9. PubMed ID: 25619635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant taurine derivatives modify taurine and GABA release in the mouse hippocampus.
    Saransaari P; Oja SS
    Proc West Pharmacol Soc; 1999; 42():27-9. PubMed ID: 10697679
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Kominek M; Florek-Luszczki M; Tchaytchian DA; Kocharov SL; Zolkowska D
    Epilepsy Res; 2012 Jun; 100(1-2):27-36. PubMed ID: 22281062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 3,4-dihydro-4-oxoquinazoline derivatives as potential anticonvulsants.
    Vaidya NA; Panos CH; Kite A; Iturrian WB; Blanton CD
    J Med Chem; 1983 Oct; 26(10):1422-5. PubMed ID: 6620301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of aryl semicarbazones as potential anticonvulsant agents.
    Yogeeswari P; Sriram D; Veena V; Kavya R; Rakhra K; Ragavendran JV; Mehta S; Thirumurugan R; Stables JP
    Biomed Pharmacother; 2005; 59(1-2):51-5. PubMed ID: 15740936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.